MSLN and neoplasm: Interestingly, chimeric antigen receptor (CAR)-T cells generated on the basis of the N-terminal region (296–390) or the glycosylated C-terminal region (487–598) demonstrated differential killing of tumor cells, suggesting, among various factors, a role in MSLN's glycosylation states in T-cell recognition (22).